---
title: "Niva Bupa Health Insurance Company Ltd (NIVABUPA) — Share Price, Financials & Analysis"
symbol: "NIVABUPA"
company: "Niva Bupa Health Insurance Company Ltd"
canonical: "https://tapetide.com/stocks/NIVABUPA"
isin: "INE995S01015"
nse_symbol: "NIVABUPA"
bse_code: "544286"
sector: "Insurance"
industry: "General Insurance"
market_cap_cr: 14628.69
generated_at: "2026-09-13T19:58:57.963Z"
---

# Niva Bupa Health Insurance Company Ltd (NIVABUPA)

Canonical page: https://tapetide.com/stocks/NIVABUPA

## Company

- **NSE Symbol:** NIVABUPA
- **BSE Code:** 544286
- **ISIN:** INE995S01015
- **Sector:** Insurance
- **Industry:** General Insurance
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Listed Since:** 2024-11-14
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** nivabupa.com

## About

Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India.[1]

## Latest Price

- **Price:** ₹79.93
- **Change:** +0.51 (+0.64%)
- **Open:** ₹79.1
- **Day High:** ₹80.36
- **Day Low:** ₹78.36
- **Previous Close:** ₹79.42
- **Volume:** 472895
- **As Of:** 2026-09-11T09:59:34+00:00

## Key Fundamentals

Observed at 2026-09-11T04:49:17.055385Z.

- **Market Cap:** ₹14628.69 Cr
- **Classification:** Microcap
- **P/E (reported):** 84.5
- **P/E (TTM):** 84.14
- **EPS (TTM):** ₹0.95
- **Book Value:** ₹20.48
- **Price to Book:** 3.88
- **Dividend Yield:** 0%
- **ROE:** 3.45%
- **ROCE:** -2.9%
- **Debt to Equity:** 0.07
- **Revenue (yearly):** ₹6696.7 Cr
- **Net Income:** ₹130.8 Cr
- **EBITDA:** ₹162.5 Cr
- **52-Week High:** ₹91.4
- **52-Week Low:** ₹67.5
- **RSI (14):** 32.15

## Tapetide Score

- **Score:** 48 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 39.4 (of 4473 scored stocks)
- **Confidence:** 97%
- **Data coverage:** 94%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 26.66 | 9% |
| growth | 82.83 | 9% |
| momentum | 74.37 | 12% |
| ownership | 59.59 | 24% |
| quality | 31.63 | 22% |
| valuation | 30.84 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has delivered good profit growth of 35.9% CAGR over last 5 years

### Weaknesses

- Stock is trading at 3.90 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 5.20% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -45.31% | 11.35% | 167.85% |
| ebitda margin growth | 1.66% | -43.62% | -5.45% | -130.88% |
| net income growth | -13.55% | -38.74% | 127% | 36% |
| revenue growth | 9.8% | 21.1% | 33% | 36% |
| roce | — | -57.29% | -43.69% | 0.09% |
| roe | — | -39.05% | 3.95% | -108.88% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 969 | 1026 | 1316 | 1124 | 1321 | 1258 | 1671 | 1932 | 1574 | 1611 | 2251 | 2471 |
| Expenses | 1027 | 1071 | 1215 | 1228 | 1387 | 1282 | 1420 | 1834 | 1627 | 1705 | 2069 | 2287 |
| Operating Profit | -58 | -46 | 100 | -103 | -66 | -24 | 251 | 98 | -53 | -94 | 182 | 184 |
| OPM % | -6 | -4.4 | 8 | -9 | -5 | -1.9 | 15 | 5 | -3.4 | -6 | 8 | 7 |
| Other Income | 50 | 50 | 57 | 84 | 79 | 37 | -45 | 0 | 18 | 7 | -1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -8 | 5 | 157 | -19 | 13 | 13 | 206 | 98 | -35 | -88 | 181 | 184 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 | 0 | 0 | 12 | 25 |
| Net Profit | -8 | 5 | 157 | -19 | 13 | 13 | 206 | 71 | -35 | -88 | 159 | 138 |
| EPS in Rs | — | — | — | — | — | 0.07 | 1.13 | 0.39 | -0.19 | -0.47 | 0.86 | 0.75 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 851 | 1057 | 1413 | 1877 | 2853 | 4115 | 5374 | 6695 | 7907 |
| Expenses | 880 | 1094 | 1435 | 2328 | 3183 | 4228 | 5292 | 6534 | 7689 |
| Operating Profit | -29 | -37 | -22 | -451 | -330 | -113 | 83 | 160 | 218 |
| OPM % | -3.4 | -3.5 | -1.5 | -24 | -12 | -2.7 | 1.5 | 2.4 | 2.8 |
| Other Income | 0 | 0 | 0 | 281 | 374 | 224 | 155 | 2 | 23 |
| Interest | 3 | 4 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 16 | 21 | 22 | 27 | 32 | 29 | 25 | 36 | 0 |
| Profit before tax | -48 | -62 | -50 | -197 | 13 | 82 | 214 | 127 | 242 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3 | — |
| Net Profit | -48 | -62 | -50 | -197 | 13 | 82 | 214 | 131 | 174 |
| EPS in Rs | — | — | — | — | — | — | 1.17 | 0.71 | 0.95 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 981 | 1126 | 1350 | 1409 | 1511 | 1700 | 1827 | 1847 |
| Reserves | -719 | -780 | -773 | -903 | -683 | 351 | 1949 | 1939 |
| Borrowings | 0 | 0 | 0 | 250 | 250 | 250 | 250 | 250 |
| Other Liabilities | 737 | 891 | 1322 | 1983 | 2799 | 3891 | 5735 | 7240 |
| Total Liabilities | 1000 | 1237 | 1899 | 2738 | 3877 | 6192 | 9760 | 11276 |
| Fixed Assets | 30 | 39 | 46 | 49 | 52 | 58 | 66 | 85 |
| CWIP | 2 | 2 | 2 | 1 | 4 | 1 | 9 | 3 |
| Investments | 816 | 1067 | 1622 | 2401 | 3366 | 5458 | 8175 | 9670 |
| Other Assets | 152 | 129 | 230 | 287 | 455 | 675 | 1510 | 1518 |
| Total Assets | 1000 | 1237 | 1899 | 2738 | 3877 | 6192 | 9760 | 11276 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | — | 257 | 338 | 593 | 813 | 1654 | 905 |
| Cash from Investing Activity | — | — | -374 | -723 | -829 | -1882 | -2348 | -961 |
| Cash from Financing Activity | — | — | 280 | 374 | 280 | 1110 | 771 | -5 |
| Net Cash Flow | — | — | 164 | -12 | 43 | 41 | 78 | -62 |
| Free Cash Flow | — | — | 229 | 309 | 555 | 780 | 1614 | 857 |
| CFO/OP | — | — | -1180 | -75 | -180 | -720 | 2000 | 577 |

### Ratios

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -264 | -270 | -290 | -341 | -313 | -298 | -351 | -354 |
| ROCE % | — | -19 | -10 | -30 | 1 | 5 | 7 | 3 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 62.94% | 55.98% | 55.98% | 55.43% | 55.41% | 55.36% | 55.36% | 55.3% |
| FIIs | 0% | 8.85% | 8.9% | 10.76% | 10.72% | 10.32% | 10.6% | 12.09% |
| DIIs | 0% | 9.83% | 9.7% | 15.06% | 15.31% | 16.04% | 16.49% | 16.17% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 0% | 4.43% | 4.23% | 5.44% | 5.4% | 5.18% | 4.56% | 3.99% |
| Others | 37.06% | 20.92% | 21.19% | 13.3% | 13.17% | 13.09% | 12.99% | 12.45% |
| No. of Shareholders | 86 | 146255 | 136017 | 154883 | 158550 | 147718 | 135343 | 126567 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 6 / 11

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 80.53 | Sell |
| EMA (10) | 80.55 | Sell |
| SMA (20) | 81.67 | Sell |
| EMA (20) | 81.6 | Sell |
| SMA (50) | 84.32 | Sell |
| EMA (50) | 82.98 | Sell |
| SMA (100) | 83.49 | Sell |
| EMA (100) | 82.47 | Sell |
| SMA (200) | 79.35 | Buy |
| EMA (200) | 81.2 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 36.14 | Neutral |
| MACD (12,26,9) | -1.32 | Sell |
| Stochastic (14,3,3) | 15.06 | Buy |
| ADX (14) | 18.51 | Neutral |
| Williams %R (14) | -73.12 | Neutral |
| ATR (14) | 1.81 | Neutral |
| ROC (12) | -2.73 | Sell |
| Stoch RSI (14) | 40.67 | Neutral |
| UO (7,14,28) | 46.18 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 9 | 90% |
| Hold | 1 | 10% |
| Sell | 0 | 0% |

Based on 10 analyst ratings, observed at 2026-09-11T04:49:17.135181+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-26 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04435d5c-bef4-4627-8d40-4013afac7114.pdf) |
| 2026-08-20 | [Receipt Of Order From The Insurance Regulatory And Development Authority Of India (IRDAI)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53f0ac92-8ef7-4be7-ac44-48b95943b440.pdf) |
| 2026-08-20 | [Announcement under Regulation 30 (LODR)-Credit Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a56d8d61-d013-454f-af91-47c0ebff6524.pdf) |
| 2026-08-13 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3534fff9-5d07-4aa0-b102-677ad265586c.pdf) |
| 2026-08-12 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3203e15-dbd7-4fc4-b8fa-5c48f94a38c2.pdf) |
| 2026-08-11 | [Receipt Of Approval From Insurance Regulatory And Development Authority Of India (IRDAI) For Appointment Of Mr. Ashwani Bhatia (DIN: 07423221) As The Chairperson Of Niva Bupa Health Insurance Company Limited (The Company)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7cca042-a1ba-4bc2-a53a-3f37d5f6c04a.pdf) |
| 2026-08-03 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57bd72c2-5ae1-493e-848d-4fc4e49da407.pdf) |
| 2026-07-30 | [Board Meeting Outcome for Outcome Of Board Meeting Held On July 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe55e7b0-d264-40aa-9c9f-78011077b42b.pdf) |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Issue of Securities](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c90be14-709b-4d52-87c5-a10eb10bd018.pdf) |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca5afb32-5057-4e12-9fa4-9185896937fc.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f559ce65-88d3-4610-b9cd-8dbf00355859.pdf) |
| 2026-05-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1111d55-b08b-40ba-a4cd-494f3c7c62d4.pdf) |
| 2026-02-03 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90f2422c-2878-4ced-89be-fe5efbaca4dc.pdf) |
| 2025-11-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a372621-6924-41e7-a02c-57476179440b.pdf) |
| 2025-08-05 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53821603-b4ad-42a9-9abc-698492f0cee4.pdf) |
| 2025-05-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ec97f00-ddf1-48bf-8c78-be138b6c308f.pdf) |
| 2025-02-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0efa2db8-1360-44fc-83fe-8b2f0b1d0093.pdf) |
| 2024-11-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6bed33ec-b9ed-40f1-b8fc-e29dc1908b70.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f35970e8-a5f3-4152-a399-aeadab3c62fb.pdf) |
| 2026-05-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=957fe837-817f-4515-8092-168e8437711f.pdf) |
| 2026-01-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=833d6359-951e-48ae-83c6-49f22ec36242.pdf) |
| 2025-11-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e0eac82-85d2-4659-bf4a-20c637f71dbb.pdf) |
| 2025-07-31 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fcd05b50-edeb-406b-a845-32493b7aca57.pdf) |
| 2025-05-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15885b3b-e678-418f-b8a4-4764e2f3ddf7.pdf) |
| 2025-02-04 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7551a914-8891-46d9-a1c8-069933910547.pdf) |
| 2024-11-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16f60d29-8042-4e3b-8611-b94835b0e6f5.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018](https://www.bseindia.com/xml-data/corpfiling/AttachHis/709543eb-8e54-45a1-b036-d194fa13e180.pdf) |
| 8 May - Company hosted audio recording of May 8, 2026 earnings call for Q4 and FY2026 results. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 8 May - Company hosted audio recording of May 8, 2026 earnings call for Q4 and FY2026 results.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b1cbc2b5-ae86-45ad-b811-bcbdc72a4ed3.pdf) |
| 8 May - Board approved two non-executive appointments, Ankur Kharbanda’s elevation, 12.25 million ESOPs, and two resignations effective May 8, 2026. | [Announcement under Regulation 30 (LODR)-Change in Management 8 May - Board approved two non-executive appointments, Ankur Kharbanda’s elevation, 12.25 million ESOPs, and two resignations effective May 8, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ce66808a-eff8-4ee5-8399-54752e73674b.pdf) |
| 8 May - Board appointed two non-executive directors, elevated Ankur Kharbanda to Deputy CEO, approved 12.25 million ESOPs, noted two resignations. | [Grant Of Stock Options 8 May - Board appointed two non-executive directors, elevated Ankur Kharbanda to Deputy CEO, approved 12.25 million ESOPs, noted two resignations.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/df8385fa-d1ae-41e3-82a5-a25bba86e6e2.pdf) |
| 8 May - Board appointed two directors, elevated Ankur Kharbanda to Deputy CEO, granted 12.25 million ESOPs; two directors resigned. | [Announcement under Regulation 30 (LODR)-Change in Directorate 8 May - Board appointed two directors, elevated Ankur Kharbanda to Deputy CEO, granted 12.25 million ESOPs; two directors resigned.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ae83720b-22d5-46d3-8b48-25f8682ace98.pdf) |
| 5 Mar - Allotment of 2,58,200 Equity shares on March 05, 2026. | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 5 Mar - Allotment of 2,58,200 Equity shares on March 05, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7c95c860-2d5a-478e-8911-40de7074fe23.pdf) |
| 30 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited FY2026 results are public. | [Closure of Trading Window 30 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited FY2026 results are public.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d5079eb3-a8dc-4e0f-9806-874109cfb64c.pdf) |
| 30 Apr - Board meets May 8, 2026 to approve audited FY26 financial results and IFRS statements; trading window closed till May 10. | [Board Meeting Intimation for Consideration And Approval Of The Financial Results For The Quarter And Year Ended March 31, 2026 30 Apr - Board meets May 8, 2026 to approve audited FY26 financial results and IFRS statements; trading window closed till May 10.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1dd2750a-e279-4aaa-a645-4216f88a82ec.pdf) |
| 30 Apr - Board meets May 8, 2026 to approve audited FY26 financial results and IFRS statements; trading window closed till May 10. | [Board Meeting Intimation for Consideration And Approval Of The Financial Results For The Quarter And Year Ended March 31, 2026 30 Apr - Board meets May 8, 2026 to approve audited FY26 financial results and IFRS statements; trading window closed till May 10.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1dd2750a-e279-4aaa-a645-4216f88a82ec.pdf) |
| 2d - Niva Bupa reported FY26 PAT of ₹366 crore, GWP ₹8,586 crore, and 80% PAT growth. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 2d - Niva Bupa reported FY26 PAT of ₹366 crore, GWP ₹8,586 crore, and 80% PAT growth.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/276505f5-8a99-4534-85f6-0f72be11939e.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-05-08 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1cbc2b5-ae86-45ad-b811-bcbdc72a4ed3.pdf) |
| 2026-01-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=937635eb-5900-44eb-a1e6-8fadff8ac3aa.pdf) |
| 2025-11-03 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4fe4633d-443f-4798-953d-45e37023f12c.pdf) |
| 2025-07-31 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2bfcc84d-ea0f-4e11-961d-8181656407af.pdf) |
| 2025-05-08 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7895add-5f51-4b03-99a2-27ad56a7057f.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8a372621-6924-41e7-a02c-57476179440b.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6bed33ec-b9ed-40f1-b8fc-e29dc1908b70.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b1111d55-b08b-40ba-a4cd-494f3c7c62d4.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b1111d55-b08b-40ba-a4cd-494f3c7c62d4.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/957fe837-817f-4515-8092-168e8437711f.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/957fe837-817f-4515-8092-168e8437711f.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4ec97f00-ddf1-48bf-8c78-be138b6c308f.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/90f2422c-2878-4ced-89be-fe5efbaca4dc.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0efa2db8-1360-44fc-83fe-8b2f0b1d0093.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/53821603-b4ad-42a9-9abc-698492f0cee4.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a00b4c4d-5183-448b-90d3-8547f4426078.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/88a45e76-3fe3-461f-ab7e-1d3d02f6e5a2.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2024-11-25 | [Un-Audited Financial Results For Quarter And Half Year Ended September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fcfd860-d892-4727-aef6-79028e0016ed.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:58:57.963Z.